Xiao Song, CFA
Chief Financial Officer | Sunnyvale, California, United States
Professional Overview
Xiao Song is an accomplished financial executive with over 15 years of experience in driving strategic financial initiatives and operational excellence. As the Chief Financial Officer at Moderna, he is responsible for overseeing the company's financial planning, reporting, and risk management, contributing to its growth and success in the biotechnology industry.
Experience Summary
Current Role
As the Chief Financial Officer at Moderna since 2018, Xiao plays a crucial role in shaping the company's financial strategy and ensuring fiscal discipline. He manages a team of finance professionals and works closely with the executive leadership to optimize financial performance, secure funding for R&D initiatives, and support the company's expansion into new markets. Under his financial stewardship, Moderna has achieved significant milestones, including securing $1.5 billion in funding to accelerate the development of its mRNA-based vaccine and therapeutic pipeline.
Career Progression
Prior to joining Moderna, Xiao served as the Chief Financial Officer at Cummins Inc., a leading manufacturer of engines and power generation products, from 2014 to 2018. In this role, he played a pivotal part in streamlining the company's global financial operations, driving cost-saving initiatives, and improving financial reporting and controls. Before that, he held the position of Finance Manager at Ecolab, where he was instrumental in implementing effective budgeting and forecasting processes, leading to enhanced financial visibility and decision-making.
Academic Background
Xiao holds a Master of Business Administration (MBA) degree from the University of California, Berkeley, with a concentration in Finance. He is also a Chartered Financial Analyst (CFA) charter holder, demonstrating his deep expertise in financial analysis and investment management.
Areas of Expertise
- Financial planning and analysis
- Capital structure optimization
- Mergers, acquisitions, and integration
- Financial reporting and risk management
- Treasury and cash flow management
- Investor relations and stakeholder management
Professional Impact
During his tenure at Cummins, Xiao spearheaded the implementation of a global finance shared services model, which resulted in a 15% reduction in operating expenses and improved financial data integrity. At Moderna, he has been instrumental in securing funding for the company's groundbreaking mRNA technology platform, positioning it as a leader in the development of innovative vaccine and therapeutic solutions.
Conclusion
Xiao Song's extensive financial acumen, strategic vision, and proven track record of driving operational and financial excellence make him a valuable asset to Moderna. As the company continues to push the boundaries of biotechnology, Xiao is well-positioned to contribute to its ongoing success and growth.
